In 2010, NIDDK sponsored a PIVENS trial (PPARγ agonist pioglitazone, vitamin E, or placebo for NASH, NCT00063622) in 247 adults with NASH without diabetes. The gene discussed is PPARG; the disease is metabolic dysfunction-associated steatohepatitis.